Visceral obesity augments prescription use: An analysis of the cross-sectional study of NHANES 2011-2018.

PLoS One · 2025 · PMC11790123 · PMID 39899523

Europe PMC DOI

hedged sentences

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

near-significantp = 0.073so close (0.05 < p ≤ 0.1)

For normal weight participants, VATob was associated with increased use of 3 and 4 prescriptions (p<0.05, Fig 3 ) and showed a near-significant association with the use of ≥5 medications (p = 0.073).

also in 1,669 other papers

a decreasing trendno p-value reported

When the cohort was stratified by BMI class, a decreasing trend in odds ratios was noted for cardiovascular and metabolic agents, with normal weight participants showing the highest odds ratio.

also in 29,529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.